Zacks Research Upgrades Omron (OTCMKTS:OMRNY) to Hold

Omron (OTCMKTS:OMRNYGet Free Report) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Monday,Zacks.com reports.

Separately, Jefferies Financial Group lowered shares of Omron from a “buy” rating to a “hold” rating in a research note on Tuesday, June 16th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold”.

Get Our Latest Report on OMRNY

Omron Stock Performance

OMRNY stock opened at $43.24 on Monday. Omron has a 1 year low of $23.23 and a 1 year high of $43.48. The stock has a market capitalization of $8.50 billion, a price-to-earnings ratio of 41.18, a PEG ratio of 0.63 and a beta of 1.14. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.41 and a current ratio of 1.83. The stock’s fifty day moving average is $35.87 and its two-hundred day moving average is $33.00.

About Omron

(Get Free Report)

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.

See Also

Receive News & Ratings for Omron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omron and related companies with MarketBeat.com's FREE daily email newsletter.